Parallel-Controlled Clinical Study on Fill-fire Needle for Vitiligo

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-14004092

Enrollment

Unknown

Registered

2014-01-06

Start date

2014-01-06

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitligo

Interventions

two groups:fill-fire needle

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18~65 years old, men and women are not limited; 2. The consistent with the clinical diagnostic criteria of Western medicine of vitiligo vulgaris; 3. The lesion area <=3% of body surface area; 4. The voluntary and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. The special parts (eye, vulva) have lesions; 2. the incidence of damage or infection; 3. in past one month, systematically used drugs of treating vitiligo or glucocorticoids; 4. Combined with serious cardiovascular and cerebrovascular disease, liver and kidney system; 5. Patients in the psychiatric patients and pregnant women, breastfeeding; 6. Other clinical trials and for 3 months in patients.

Design outcomes

Primary

Measure	Time frame
Vitiligo Area and Severity Index;	—

Countries

China

Contacts

Public ContactGUO FEI

Xinjiang Medical University Affiliated Hospital of Traditional Chinese Medicine

407113163@qq.com+86 15276783925

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026